Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Clinical research trials and Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1. Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 clinical trial. Human subjects often obtain the finest healthcare possible for their Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "B" Clinical Trials Conditions > Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1



Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

For Condition: Opioid-Related Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: (1) Compare subjects response to liquid vs. tablet formulations; (2) Assess bioequivalency of liquid vs. tablet; (3) Compare subject preference; (4) Evaluate if dose response curve for tablet equal to liquid form.
Details: 1) Compare subjects response to liquid vs tablet formulation 2) Assess bioequivalency of liquid vs tablet 3)Compare subject preference 4) Evaluate if dose response curve for tablet = to liquid form
Eligibility:
Study Type:
  Interventional, Treatment, Double-Blind, Uncontrolled, Crossover Assignment
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: M/F ages 18-65. Meet DMS-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Pregnant or nursing women. Acute medical condition that would interfere with study participation or put safety of subjects in jeopardy. Current daily use of anti-convulsants, antabuse or neuroleptics. DSM-IV diagnosis of ETOH or sedative/hypnotics dependence.
Total Enrollment: 0

Location and Contact Information:

Overall Study Official:
WalterLing,  Principal Investigator,  Friends Research Institute

Friends Research Institute
Los Angeles,  California,  90025
United States
 


Additional Information:
Study ID Numbers:
  NIDA-10068-1;  R01-10068-1
Study Start Date: October 1997
Record last reviewed: October 1997
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000320

Other Opioid-Related Disorders Studies:
1. Effects of Combined Alcohol and Nitrous Oxide Intake - 15

2. PK0496 Pharmacokinetics of Buprenorphine - 10

3. Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

4. Buprenorphine Dosing Interval - 5

5. Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

Related Studies:

Other Opioid-Related Disorders Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Modify your Search

  Other Opioid-Related Disorders Clinical Trials
  Other California Clinical Trials
  Other Los Angeles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103